The latest ↗

StocksSTORIES WITH TASTE
Penny Stocks

TCRT: A $350 Million Biotech Deal Makes Dilution the Essential Question

Alaunos’ Velaris acquisition brings capital and a new development opportunity. The investment case depends on the ownership investors receive, not the small market cap shown on an app.

Read the story